- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00088283
Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)
A Phase II Randomized, Dose-Ranging, Double-Masked, Multi-Center Trial, in Parallel Groups, Determining Safety, Efficacy and PK of Intravitreous Injections of Pegaptanib Sodium Compared to Sham Injection for 30 Weeks in Patients With Recent Vision Loss Due to Macular Edema Secondary to CRVO
Eyetech Pharmaceuticals Inc. and Pfizer, Inc. are studying an investigational drug, MacugenTM, for the possible treatment of CRVO. An investigational drug is one that has not been approved by the U.S. Food and Drug Administration (FDA). This investigational drug may slow the growth of abnormal blood vessels in the eye and may reduce tissue swelling in the eye.
The purpose of this study is to compare the safety and efficacy of a Macugen™ injection to a "pretend" injection. In addition, the purpose of this study is to measure the action of the study drug in the body over a period of time and to check for the presence of the study drug in your blood (called pharmacokinetics or PK).
This study will involve approximately 90 people. People who decide to participate will have an equal chance (1 in 3) to receive one of three study injections, two of which are Macugen™ and one of which is a "pretend" injection.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Studietype
Registrering
Fase
- Fase 2
Kontakter og plasseringer
Studiesteder
-
-
Arizona
-
Tucson, Arizona, Forente stater, 85704
- Retina Centers, P.C., Northwest Location
-
Tucson, Arizona, Forente stater, 85710
- Retina Associates, SW
-
-
California
-
Los Angeles, California, Forente stater, 90095
- Jules Stein Institute
-
Santa Ana, California, Forente stater, 92705
- Orange County Retina Associates
-
-
Connecticut
-
Hamden, Connecticut, Forente stater, 06518
- New England Retina Associates
-
-
Florida
-
Fort Lauderdale, Florida, Forente stater, 33334
- Retina Group of Florida
-
Miami, Florida, Forente stater, 33136
- Bascom Palmer Eye Institute
-
-
Illinois
-
Chicago, Illinois, Forente stater, 60637
- The University of Chicago
-
-
Indiana
-
Indianapolis, Indiana, Forente stater, 46280
- Macula-Retina-Vitreous Service
-
-
Kansas
-
Wichita, Kansas, Forente stater, 67214
- Vitreo-Retinal Consultants & Surgeons, P.A.
-
-
Louisiana
-
New Orleans, Louisiana, Forente stater, 70155
- Retina Associates
-
-
Maryland
-
Chevy Chase, Maryland, Forente stater, 20815
- Retina Group of Washington
-
Hagerstown, Maryland, Forente stater, 21740
- Cumberland Valley Retina Center
-
-
Massachusetts
-
Boston, Massachusetts, Forente stater, 02114
- Massachusetts Eye & Ear Infirmary
-
Boston, Massachusetts, Forente stater, 02111
- New England Eye Center
-
Peabody, Massachusetts, Forente stater, 01960
- Lahey Clinic, The Eye Institute
-
-
Michigan
-
Detroit, Michigan, Forente stater, 48201
- Kresge Eye Institute
-
Royal Oak, Michigan, Forente stater, 48073
- Associated Retinal Consultants
-
-
Missouri
-
Kansas City, Missouri, Forente stater, 64108
- Eye Foundation of Kansas City
-
-
North Carolina
-
Charlotte, North Carolina, Forente stater, 28210
- Charlotte Eye, Ear, Nose and Throat Associates, P.A.
-
Durham, North Carolina, Forente stater, 27710
- Duke University Eye Center
-
-
Ohio
-
Cleveland, Ohio, Forente stater, 44195
- The Cleveland Clinic
-
Lakewood, Ohio, Forente stater, 44107
- Retina Associates of Cleveland Inc.
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forente stater, 73104
- Dean A. McGee Eye Institute
-
-
Oregon
-
Portland, Oregon, Forente stater, 97239
- Casey Eye Institute
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forente stater, 19107
- Wills Eye Institute Retina Research
-
-
South Carolina
-
Columbia, South Carolina, Forente stater, 29204
- Palmetto Retina Center
-
-
Tennessee
-
Knoxville, Tennessee, Forente stater, 37909
- Southeastern Retina Associates
-
-
Texas
-
Abilene, Texas, Forente stater, 79606
- Retina Research Institute of Texas, LLC
-
Austin, Texas, Forente stater, 78705
- Austin Retina Associates
-
Dallas, Texas, Forente stater, 75231
- Texas Retina Associates
-
Houston, Texas, Forente stater, 77030
- Vitreoretinal Consultants
-
McAllen, Texas, Forente stater, 78503
- Valley Retina Associates, P.A.
-
-
Wisconsin
-
Madison, Wisconsin, Forente stater, 53705
- University of Wisconsin
-
Milwaukee, Wisconsin, Forente stater, 53226
- The Eye Institute
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- CRVO must have occurred within the past 6 months and be associated with macular edema determined by OCT.
- Vision in the study eye corresponding to between approximately 20/50 to 20/400 and better than or equal to approximately 20/200 in the fellow eye.
Exclusion Criteria:
- Presence of signs of old branch retinal vein occlusion (BRVO) or CRVO in the study eye or any other retinal vascular disease including diabetic retinopathy.
- Vitreous hemorrhage except breakthrough hemorrhage from intraretinal hemorrhage.
- Prior pan retinal photocoagulation (PRP) or sector scatter photocoagulation.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- EOP 1011B
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .